BREAKING: Dark Horse Consulting Group acquires BioTechLogic, Inc.
Meet BioTechLogic at any of these events!
Send an email to contact@biotechlogic.com and let us know which event you’d like to schedule time to meet.
Excellence in Clinical Trials, Biologics Innovation and Expanded Manufacturing for Australia’s Future Biologics Industry.
With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers and regulation, Australia has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia will also play a massive role in uplifting the sector in the country.
The Australia Biologics Festival 2025 is Australia’s premier conference that aims to gather the innovators, pioneers ,leaders in the Biologics fraternity including Biologics,Biosimilars, Vaccines, CGT and evolving therapeutics to showcase the latest from ideation to commercialization phase and beyond. The themes of Investment in Australia and Promoting Clinical Trials in Australia in featured tracks. It brings the right environment to meet the entire biopharma fraternity under one roof.
Join us to bring investment to Australia’s bio sector and explore a wealth of opportunities in world-class clinical trials and biologics innovation as well as expanding the country’s manufacturing footprint.
We’re looking forward to connecting and to the potential of supporting your program. Schedule a meeting while at the show here.
BioTechLogic, Inc., is a biopharmaceutical manufacturing and CMC consulting firm with strategic, practical, and hands-on experience that helps clients bring their products to market quickly and successfully by augmenting and optimizing an organization's technical, manufacturing, analytical, and regulatory resources.
Access our on-demand webinar that discusses proactive quality system management that allow pharmaceutical manufacturers to avoid time and resource-intensive filing approval delays, observations, and warning letters. • Deviation, CAPA & change control management•...
Article originally published on GEN The biotechnology industry achieved many firsts this past year, from the first approved drug that can slow the rates of cognitive and functional decline in adults with Alzheimer’s disease, to the first CRISPR-based gene editing...
© 2024 BIOTECHLOGIC, INC | ALL RIGHTS RESERVED